Company Monitoring Page for Pfizer

latest headlines for company on cafepharma

Why Pfizer’s Vaccines Business Is Declining
Market Realist
Fri, 09/2/16 - 09:35 am
Tags:
Pfizer, vaccines
Pfizer Gets European Approval For XALKORI, A Cell Lung Cancer Treatment
Yahoo/Benzinga
Thu, 09/1/16 - 09:23 am
Tags:
Pfizer, Europe, Xalkori, non-small cell lung cancer
$354M exit package in hand, Medivation CEO David Hung completes a master class in biotech auctions
Endpoints
Wed, 08/31/16 - 09:09 pm
Tags:
Medivation, Pfizer, David Hung, M&A, executive pay
Is Pfizer Paying Too Much to Buy Medivation?
Motley Fool
Wed, 08/31/16 - 08:43 pm
Tags:
Pfizer, Medivation, M&A
Could Pfizer Face An Apple-Like Tax Surprise in the EU?
Motley Fool
Wed, 08/31/16 - 09:12 am
Tags:
Pfizer, Europe, taxes
Gilead Was Smart to Let Medivation Slip Through its Fingers
Yahoo/GuruFocus
Tue, 08/30/16 - 09:53 am
Tags:
Gilead Sciences, Medivation, Pfizer, Sanofi, M&A
In Wake Of Medivation Deal, Argus Thinks Pfizer's Existing Business Is Underrated
Yahoo/Benzinga
Tue, 08/30/16 - 09:51 am
Tags:
Medivation, Pfizer, Argus, M&A
Ibrance and Xtandi Could Be in the Top 10 Oncology Drugs by 2021
Market Realist
Mon, 08/29/16 - 04:16 pm
Tags:
Ibrance, Xtandi, oncology, Pfizer, Medivation, breast cancer, prostate cancer
Game On for Pfizer With $14 Billion Medivation Buyout (or, Why Pfizer's Buyout of Medivation Could Be a Smart Move)
Motley Fool
Fri, 08/26/16 - 10:00 am
Tags:
Pfizer, Medivation, M&A, oncology, Ibrance
Pfizer Inc. Can Stall the Decision to Split — Thanks to Medivation Inc
Bidness, ETC
Thu, 08/25/16 - 10:13 pm
Tags:
Pfizer, Medivation, M&A
MedImmune won't be impacted by AstraZeneca sale of antibiotic business to Pfizer
Bizjournals.com
Thu, 08/25/16 - 09:51 am
Tags:
AstraZeneca, Pfizer, MedImmune, antibiotics, M&A
How Mylan And Pfizer Could Cause A Major Biotech Backlash
Forbes
Thu, 08/25/16 - 09:47 am
Tags:
Mylan Labs, Pfizer, EpiPen, Xtandi
AstraZeneca to sell molecule antibiotics business to Pfizer
Yahoo/AP
Wed, 08/24/16 - 11:00 am
Tags:
AstraZeneca, Pfizer, M&A, antibiotics
Pfizer Has Had A Busy M&A Year...Or Has It?
Yahoo/Benzinga
Wed, 08/24/16 - 10:42 am
Tags:
Pfizer, M&A, Medivation, Allergan, AstraZeneca
Drugmakers revive R&D focus on long stagnant women's health market
Medical Marketing and Media
Tue, 08/23/16 - 10:50 am
Tags:
R&D, Women's Health, innovation, Myovant Sciences, Amgen, UCB Pharma, breast cancer, Pfizer, S1 Biopharma, Ibrance, Addyi
What Pfizer Gets in Its $14 Billion Medivation Deal
Motley Fool
Tue, 08/23/16 - 10:02 am
Tags:
Pfizer, Medivation, M&A, Xtandi, prostate cancer, talazoparib, pidilizumab
True or false? In an alternate universe, Sanofi played nice and won Medivation
Fierce Pharma
Tue, 08/23/16 - 09:59 am
Tags:
Sanofi, Medivation, Pfizer, M&A
Pfizer's Medivation buy seen prescribing more biotech M&A
Yahoo/Reuters
Mon, 08/22/16 - 10:30 pm
Tags:
Pfizer, Medivation, M&A, biotech, Vertex Pharmaceuticals, Alexion, Neurocrine, Intercept Pharma
Pfizer to shed four Hospira sites
BioPharma Dive
Mon, 08/22/16 - 11:52 am
Tags:
Pfizer, Hospira, distribution, layoffs
Pfizer spent $14 billion on a company with just one approved drug — here's why that's a game changer
Yahoo/Business Insider
Mon, 08/22/16 - 11:43 am
Tags:
Pfizer, Medivation, M&A, Sanofi, Xtandi, prostate cancer, pidilizumab, talazoparib

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.